Alpine Clinical Research Center
Generated 5/9/2026
Executive Summary
Alpine Clinical Research Center, founded in 1994, is an independent clinical research site based in Boulder, Colorado. With over 30 years of experience, the center collaborates with major pharmaceutical companies to evaluate the safety and efficacy of new treatments across various therapeutic areas, including metabolic, cardiovascular, and central nervous system disorders. The site leverages strong relationships with local physicians and the Boulder medical community to ensure efficient patient recruitment and retention. By offering Phase I-IV trial capabilities, Alpine plays a critical role in the drug development pipeline, though it faces competition from larger site networks and academic centers. The company's independent status allows for operational flexibility and close collaboration with sponsors, positioning it for continued growth as clinical trial outsourcing expands. To maintain relevance, Alpine must invest in expanding its therapeutic expertise and adopting decentralized trial technologies.
Upcoming Catalysts (preview)
- Q3 2026New multi-year contract with a top-20 pharma sponsor70% success
- TBDExpansion into CNS or rare disease trials50% success
- TBDFDA approval of a key drug tested at the site30% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)